European Commission

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

UCB brings first therapy for rare disease TK2d to EU

The EU has approved UCB's Kygevvi for rare disease TK2d, and Sanofi's acute GvHD therapy Rezurock, in a pair of decisions announced this morning.

News

Agreement reached on EU's new pharma legislation

Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.

News

Sanofi faces EU antitrust probe into vaccine business

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

News

EU-US trade deal includes 15% pharma tariff

Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.

News

Merck unit gets first EU nod for a desmoid tumour treatment

Merck unit SpringWorks has claimed EU approval for Ogsiveo, becoming the first approved therapy for desmoid tumours in Europe.

EU invests €30m to fight antimicrobial resistance

UCB brings first therapy for rare disease TK2d to EU

Agreement reached on EU's new pharma legislation

Sanofi faces EU antitrust probe into vaccine business

EU-US trade deal includes 15% pharma tariff

Merck unit gets first EU nod for a desmoid tumour treatment

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

European Commission

Editor's Picks